Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of thyroid dysfunction on drug pharmacokinetics.

Literature DB >> 6166422

Influence of thyroid dysfunction on drug pharmacokinetics.

G M Shenfield.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1981 PMID： 6166422 DOI： 10.2165/00003088-198106040-00003

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

138 in total

Review 1. DRUG TOXICITY AS A RESULT OF INTERFERENCE WITH PHYSIOLOGICAL CONTROL MECHANISMS.

Authors: J R GILLETTE
Journal: Ann N Y Acad Sci Date: 1965-03-12 Impact factor: 5.691

2. Liver function related to thyroxine metabolism.

Authors: L VAN MIDDLESWORTH; J A TURNER; A LIPSCOMB
Journal: J Nucl Med Date: 1963-03 Impact factor: 10.057

3. Contrasting effects of thyroxin on zoxazolamine and hexobarbital metabolism.

Authors: A H CONNEY; L GARREN
Journal: Biochem Pharmacol Date: 1961-06 Impact factor: 5.858

4. Specific (3H) ouabain binding to rat heart and skeletal muscle: effects of thyroidectomy.

Authors: V K Sharma; S P Banerjee
Journal: Mol Pharmacol Date: 1978-01 Impact factor: 4.436

5. Digoxin kinetics in patients with thyroid dysfunction.

Authors: J R Lawrence; D J Sumner; W J Kalk; W A Ratcliffe; B Whiting; K Gray; M Lindsay
Journal: Clin Pharmacol Ther Date: 1977-07 Impact factor: 6.875

6. The pharmacokinetics of propylthiouracil.

Authors: J Kampmann; L Skovsted
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1974-11

7. [Influence of thyroid function on human drug metabolism].

Authors: R Gugler; M Eichelbaum; C Schneider-Deters; G Bodem; H J Dengler
Journal: Verh Dtsch Ges Inn Med Date: 1973

Review 8. Thyroid hormone and the kidney.

Authors: A I Katz; D S Emmanouel; M D Lindheimer
Journal: Nephron Date: 1975 Impact factor: 2.847

9. The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.

Authors: R A Branch; A S Nies; D G Shand
Journal: Drug Metab Dispos Date: 1973 Sep-Oct Impact factor: 3.922

Review 10. Drug metabolism in thyroid disease.

Authors: M Eichelbaum
Journal: Clin Pharmacokinet Date: 1976 Impact factor: 6.447

29 in total

Review 1. A concomitant review of the effects of diabetes mellitus and hypothyroidism in wound healing.

Authors: Konstantinos A Ekmektzoglou; Georgios C Zografos
Journal: World J Gastroenterol Date: 2006-05-07 Impact factor: 5.742

2. Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism.

Authors: George Chinedu Ezeji; Taiga Inoue; Gul Bahtiyar; Alan Sacerdote
Journal: BMJ Case Rep Date: 2015-02-09

Review 3. Thyrotoxic atrial fibrillation.

Authors: Malvinder S Parmar
Journal: MedGenMed Date: 2005-01-04

Influence of thyroid dysfunction on drug pharmacokinetics.

Review 1. DRUG TOXICITY AS A RESULT OF INTERFERENCE WITH PHYSIOLOGICAL CONTROL MECHANISMS.

2. Liver function related to thyroxine metabolism.

3. Contrasting effects of thyroxin on zoxazolamine and hexobarbital metabolism.

4. Specific (3H) ouabain binding to rat heart and skeletal muscle: effects of thyroidectomy.

5. Digoxin kinetics in patients with thyroid dysfunction.

6. The pharmacokinetics of propylthiouracil.

7. [Influence of thyroid function on human drug metabolism].

Review 8. Thyroid hormone and the kidney.

9. The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.

Review 10. Drug metabolism in thyroid disease.

Review 1. A concomitant review of the effects of diabetes mellitus and hypothyroidism in wound healing.

2. Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism.

Review 3. Thyrotoxic atrial fibrillation.

4. Heart failure in thyrotoxicosis, an approach to management.

5. Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.

Review 6. The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Review 7. Thyroid disease in older patients. Diagnosis and treatment.

8. Impaired nitrazepam metabolism in hypothyroidism.

Review 9. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

10. Oxazepam pharmacokinetics in thyroid disease.